Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients
Condition: Primary Open Angle Glaucoma Interventions: Drug: Latanoprost 0.005% Ophthalmic Solution; Drug: Travoprost 0.004% ophthalmic solution; Drug: Tafluprost Ophthalmic 0.0015% Ophthalmic Solution Sponsor: Kasr El Aini Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials